Clinical trial
Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery…
NCT00470184 · Roswell Park Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00470184 |
|---|---|
| Title | Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer |
| Official title | Phase II Study of Capecitabine in Combination With Oxaliplatin and Radiotherapy for Esophageal and Gastroesophageal Junction Cancer |
| Lead sponsor | Roswell Park Cancer Institute, Other |
| Collaborators | National Comprehensive Cancer Network |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug, Genetic, Procedure, Radiation |
| Interventions | capecitabine, oxaliplatin, gene expression analysis, microarray analysis, reverse transcriptase-polymerase chain reaction, adjuvant therapy, biopsy, conventional surgery, neoadjuvant therapy, quality-of-life assessment and 1 more |
| Enrollment | 41 |
| Start date | Nov 1, 2006 |
| Primary completion | Oct 1, 2012 |
| First posted | May 7, 2007 |
| Last update posted | Nov 25, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: